CDC Website CDC Website

To Join the NPIN community or

You are here


COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Gilead Research Scholars Program

The program is designed to support basic and clinical research in the field of HIV, in North America and globally. Areas of research may include, but are not limited to: basic, translational, clinical, behavioral and epidemiological research; management of complications, comorbidities and/or co-infections; prevention; health economics outcomes research.

Service Area Competition

This notice announces the opportunity to apply for funding under the Health Center Program’s Service Area Competition (SAC). The Health Center Program supports domestic public or private, nonprofit community-based and patient-directed organizations that provide primary health care services to the Nation’s medically underserved populations. The purpose of the SAC notice of funding opportunity (NOFO) is to ensure continued access to comprehensive, culturally competent, high-quality primary health care services for communities and populations currently served by the Health Center Program.

Global Reach II

This notice announces the opportunity to apply for funding under the Global Reach Program. The purpose of this initiative is to collaboratively formulate and deliver high quality solutions across the range of programming required to achieve sustainable HIV epidemic control as guided by the Office of the Global AIDS Coordinator of the U.S. State Department, emphasizing new and innovative approaches pursued jointly with HRSA and other stakeholders.

Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including methamphetamine, amphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

NIDA is interested in research that addresses research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.

Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)

he purpose of this FOA is encourage and support the development of effective strategies for expanding the provision of HIV pre-exposure prophylaxis (PrEP) in sexually transmitted infection (STI) service settings in high priority jurisdictions identified by the presidential initiative, Ending the HIV Epidemic: A Plan for America. Funding for the fourth and fifth years (s) will be dependent upon achieving negotiated go/no go criteria and milestones.


Subscribe to RSS - Colleges/Universities